Extramural Funding

Print

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited and applications be managed directly by the JCCC. If you have any questions about a specific opportunity listed below, please email Nancy Presseau at npresseau@mednet.ucla.edu.

Listings are generally updated on a monthly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.


Posted September 22, 2022

Kure It Barry Hoeven Memorial Cancer Research Project

Deadline: Full application due October 31, 2022.

How to apply: Click here to download the application instructions.

Overview: The proposed research project should be a new project intended to support clinical and translational work to advance the treatment approach to kidneycancer that is not receiving significant funding from any other source. Applicants will need to justify "underfunded" in the context of cancer research and how the proposed research project fits that definition. All faculty in any series, including adjunct and professional research series, are eligible to apply; Instructor, Assistant Professors, Associate Professors, and Professors.Postdoctoral fellows are not eligible.

The amount of funding available for this grant is $250,000. One grant will be awarded. The duration allows for one- to three-year terms at the discretion of the investigator. The funding provided herein is intended to support clinical and translational work to advance the treatment approach tokidneycancer


NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (Independent Clinical Trial Not Allowed)

Deadline: Research summary and biosketch due by November 4, 2022 / full application due: February 28, 2023.

How to apply: Please send a one-page research summary and your NIH Biosketch to Nancy Presseau at npresseau@mednet.ucla.edu.

Overview: The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to work with their institutions to apply. For more information, visit the NCI website.


NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (Independent Clinical Trial Required)

Deadline: Research summary and biosketch due by November 4, 2022 / full application due: February 28, 2023.

How to apply: Please send a one-page research summary and your NIH Biosketch to Nancy Presseau at npresseau@mednet.ucla.edu.

Overview: The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to work with their institutions to apply.

 For more information, visit the NCI website.


NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (Independent Basic Experimental Studies with Humans Required)

Deadline: Research summary and biosketch due by November 4, 2022 / full application due: February 28, 2023.

How to apply: Please send a one-page research summary and your NIH Biosketch to Nancy Presseau at npresseau@mednet.ucla.edu.

Overview: The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to work with their institutions to apply. For more information, visit the NCI website.


Posted August 18, 2022

Michelson Philanthropies & Science Prize for Immunology

Deadline: Application due by October 1, 2022.

How to apply: Please click here to visit their website.

Overview: The Michelson Philanthropies & Science Prize for Immunology focuses on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery.

This international prize supports investigators 35 and younger, who apply their expertise to research that has a lasting impact on vaccine development and immunotherapy. It is open to researchers from a wide range of disciplines including computer science, artificial intelligence/machine learning, protein engineering, nanotechnology, genomics, parasitology and tropical medicine, neurodegenerative diseases, and gene editing.


Posted July 18, 2022

2022 V Foundation Pediatric Research Grant

Deadline: Proposal due to JCCC: August 22, 2022 / Full proposal due: October 17, 2022

How to apply: To be considered, please email a one-page research proposal and biosketch (NIH format only) to Nancy Presseau at npresseau@mednet.ucla.edu.

Overview: Due to exceptional fundraising levels in 2022, the V Foundation is offering an additional pediatric cancer research grant opportunity. This grant opportunity will be implemented through one of three grant mechanisms: V Scholar, Translational, or All-Star grant types. Award amounts will be significantly larger for each of these mechanisms and strict eligibility criteria for each are listed below.

This request for applications is specifically for pediatric cancer research utilizing three different grant mechanisms.

  • V Scholar grant applicants can propose pediatric cancer research that is focused on laboratory research that increases our understanding of cancer biology or translational type research that improves cancer detection, prevention, treatment, and survivorship.
  • Translational grant applicants can propose pediatric cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential.
  • All-Star grant applicants must have previously received a V Foundation grant (V Scholar, Translational or Designated cancer research grant) to be eligible to apply for the All-Star grant.

Grant specifics for V Scholar recipients is $600,000, paid in three annual installments; Translational recipients is $800,000, paid in four annual installments; and All Star recipients is $1,000,000, paid in five annual installments.